修改草中acequinocyl现有的最大残留水平
EFSA journal. European Food Safety Authority
|January 22, 2025
概括
草中阿西基诺基的最大残留量被审查,并根据室内良好农业实践 (GAP) 提出了修改建议. 残留物监测是可行的,消费者健康风险被认为不太可能.
科学领域:
- 食品安全 食品安全
- 农药法规 农药法规 农药法规
- 农业科学 农业科学
背景情况:
- 欧盟396/2005条例规定了食品中的农药残留物限值.
- 农业-Kanesho Kabushiki Kaisha 要求修改草中的阿塞奎诺基MRL.
- 该请求已提交给希腊国家当局.
研究的目的:
- 评估数据,以修改草中的acequinocyl最大残留量 (MRL).
- 根据室内良好农业实践 (GAP) 制定一个MRL建议.
- 评估与消费者摄入acequinocyl残留物相关的风险.
主要方法:
- 对草中阿塞奎诺基基残留物水平的提交数据的审查.
- 对残留物执法分析方法的评估.
- 对消费者健康的毒理风险评估.
主要成果:
- 数据支持使用室内GAP的草中acequinocyl的MRL建议.
- 有分析方法可用于强制执行,量化极限 (LOQ) 为0.01 mg/kg.
- 风险评估表明,残留物没有显著的短期或长期健康风险.
结论:
- 草中acequinocyl的建议MRL得到了提交的数据的支持.
- 通过当前的分析方法,可以实现acequinocyl残留的强制执行.
- 通过饮食摄入acequinocyl残留物不太可能对公众健康构成风险.
更多相关视频
05:20Avocado Sample Preparation Using the QuEChERS Method with Ammonium Formate for Pesticide Analysis
Published on: December 8, 2023
578
10:24Author Spotlight: Quantification of Aflatoxins and Phytoalexins in Peanut Seeds to Identify Genetic Resistance Against Aspergillus
Published on: April 19, 2024
1.0K
相关概念视频
Clinically Relevant Drug Product Specifications: Methods of Establishment
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
FDA Approved Drugs: Changes to Approved Drugs
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
